Glenmark Pharmaceuticals (GLENMARK.NSE) Q1 2025 Earnings

15FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-43.97
-24.38
-4.78
14.82

Details

Expected EPS
14.18652827856
Actual EPS
12.41952297696
Surprise EPS
-1.77
Surprise Percent
+12.46%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 12.41952297696 per share for Q1 2025.

0 Comments

Share your thoughts